Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2002
08/15/2002US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH)
08/15/2002US20020110539 Modulated release particles for lung delivery
08/15/2002CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
08/15/2002CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods
08/14/2002EP1230270A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents
08/14/2002EP1229935A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
08/14/2002EP0665853B1 Multimeric polyvalent antithrombotic agents
08/13/2002US6433143 Tie-2 ligands
08/13/2002US6432667 Polynucleotide encoding TIE-2 ligand-4
08/13/2002US6432382 Measurement of gastric emptying using stable isotopes
08/12/2002WO2001034196A2 Mixture containing rare earths and use thereof
08/12/2002CA2398832A1 Mixture containing rare earths and use thereof
08/08/2002WO2002060955A2 Modified antibodies and methods of use
08/08/2002WO2002060923A2 B-superfamily conotoxins
08/08/2002WO2002060903A1 Substituted indolines as 5-ht receptor ligands
08/08/2002WO2002060524A2 Enhanced ultrasound detection with temperature dependent contrast agents
08/08/2002WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
08/08/2002WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
08/08/2002WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders
08/08/2002WO2002000170A3 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
08/08/2002WO2001097858A3 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination
08/08/2002WO2001091806A9 Measurement of the therapeutic dose for bone marrow ablation therapy
08/08/2002WO2001089380A3 Combined impedance imaging and mammography
08/08/2002US20020106325 Administering to mammal vitronectin receptor targeted imaging agent and a perfusion imaging agent; concurrently detecting vitronectin receptor targeted imaging agent bound at vitronectin receptor and perfusion imaging agent; imaging
08/08/2002US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family
08/08/2002CA2766160A1 Molecules with extended half-lives, compositions and uses thereof
08/08/2002CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders
08/08/2002CA2436092A1 Modified antibodies and methods of use
08/08/2002CA2435395A1 Enhanced ultrasound detection with temperature dependent contrast agents
08/08/2002CA2429969A1 Substituted indolines as 5-ht receptor ligands
08/08/2002CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
08/07/2002EP1228369A1 Method and means for detecting inflammatory processes
08/07/2002EP1228208A2 36p6d5: secreted tumor antigen
08/07/2002EP1227849A2 Actinium-225 complexes and conjugates for radioimmunotherapy
08/07/2002EP1227845A2 Mixture containing rare earths and use thereof
08/07/2002EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
08/06/2002US6429297 Modified avidin and streptavidin and methods of use thereof
08/06/2002US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction
08/06/2002US6428768 Stabilized radiopharmaceutical kits
08/01/2002WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
08/01/2002WO2002059264A2 Specific human antibodies for selective cancer therapy
08/01/2002WO2002058775A2 Device for dilating and irradiating a vascular segment or body passageway
08/01/2002WO2002058741A2 Treatment of cancer with positron-emitting radiopharmaceuticals
08/01/2002WO2002058740A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
08/01/2002WO2002058531A2 Ingestible device
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002WO2002007783A3 Radiolabeled immunotoxins
08/01/2002WO2001097862A3 Stabiliser for radiopharmaceuticals
08/01/2002WO2001093918A3 Radioimaging probes and the use thereof
08/01/2002WO2001082978A3 Imaging of nicotinic acetylcholine receptor subtypes
08/01/2002WO2001075110A3 Mucin-1 specific binding members and methods of use thereof
08/01/2002US20020103410 Methods and implants for providing radiation to a patient
08/01/2002US20020103341 Annexin derivatives with endogenous chelation sites
08/01/2002US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease
08/01/2002US20020102217 For use in ultrasound imaging, contrast agents
08/01/2002US20020102216 Enhanced ultrasound detection with temperature-dependent contrast agents
08/01/2002US20020102215 Diagnostic/therapeutic agents
08/01/2002US20020102209 For imaging renal tissues
08/01/2002US20020102207 Method of chemical marking for identifying fish stocks such as salmon using strontium chloride or hygroscopic compounds, thereof
08/01/2002CA2435205A1 Ingestible device
08/01/2002CA2433227A1 Specific human antibodies for selective cancer therapy
08/01/2002CA2431313A1 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
07/2002
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP0961591A4 Method to enhance tissue accumulation of radiolabeled compounds
07/31/2002EP0810883B1 Conjugate comprising dtpa and albumin for individual medicament dosing
07/30/2002US6426400 Complexes
07/30/2002CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives
07/30/2002CA2103554C Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
07/30/2002CA2084187C 99m tc labeled liposomes
07/25/2002WO2002057786A2 Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
07/25/2002WO2002057741A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
07/25/2002WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
07/25/2002WO2002056747A2 Radioactive medical devices for inhibiting a hyperplastic response
07/25/2002WO2002056670A2 Activatable imaging probes
07/25/2002US20020099184 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction
07/25/2002US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor
07/25/2002US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it
07/25/2002US20020098149 Tetraaza or hexaaza tricylic derivatives or salts containing radionuclide; useful as x-ray or MRI contrast agent
07/25/2002US20020098148 Radiolabelled substituted carbonylaminobenzene derivatives which bind androgen recepotr
07/25/2002CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
07/25/2002CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
07/24/2002EP1224943A1 Fibronectin as a tumor marker detected by phage antibodies
07/24/2002EP1224461A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
07/24/2002EP0835263B9 Somatostatin peptides
07/24/2002EP0693941B1 Radiolabeled compounds for thrombus imaging
07/24/2002EP0689463B1 Imidazole based nitrogen-sulfur ligands useful in radiographic imaging agents
07/24/2002CN1087955C Technetium-99m labeled imaging agents
07/23/2002US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof
07/23/2002US6423498 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
07/18/2002WO2002056015A1 Marker for inflammatory conditions
07/18/2002WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
07/18/2002WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes
07/18/2002WO2002055112A2 Polypodal chelants for metallopharmaceuticals
07/18/2002WO2002055111A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
07/18/2002WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods
07/18/2002WO2001081544A3 Identification and uses of a hyaluronan receptor
07/18/2002WO2001068142A9 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
07/18/2002US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias
07/18/2002US20020094316 Polypodal chelants for metallopharmaceuticals
07/18/2002CA2434269A1 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms